BioAge Labs (BIOA) Change in Receivables (2025 - 2026)

BioAge Labs' (BIOA) quarterly Change in Receivables came in at -$60000.0 in Q1 2026, down 116.62% year-on-year from $361000.0 in Q1 2025, and down 123.62% quarter-over-quarter from $254000.0 in Q4 2025.

BioAge Labs (BIOA) Change in Receivables (2025 - 2026) Analysis & Trends

BioAge Labs has disclosed Change in Receivables across 2 years of filings, most recently posting -$60000.0 for Q1 2026.

  • Change in Receivables for Q1 2026 came in at -$60000.0, down 116.62% year-over-year; the trailing twelve-month figure through Mar 2026 was $348000.0 (down 3.6% YoY), and the FY2025 annual result was $769000.0, changed N/A from the prior year.
  • Change in Receivables came in at -$60000.0 for Q1 2026 at BioAge Labs, down from $254000.0 in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $361000.0 in Q1 2025 to a low of -$88000.0 in Q3 2025.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Receivables (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn -78.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 106.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -38.20 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 81.40 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 23.22 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 116.25 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 2.23 Mn
10 BioAge Labs 671.19 Mn 288.00 Mn -10.37 Mn -60,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -60,000.00
Mar 31, 2026 -60,000.00
Dec 31, 2025 254,000.00
Dec 31, 2025 254,000.00
Sep 30, 2025 -88,000.00
Sep 30, 2025 -88,000.00
Jun 30, 2025 242,000.00
Jun 30, 2025 242,000.00
Mar 31, 2025 361,000.00
Mar 31, 2025 361,000.00